Pharmadax Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMADAX INC, and what generic and branded alternatives to PHARMADAX INC drugs are available?
PHARMADAX INC has six approved drugs.
Drugs and US Patents for Pharmadax Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmadax Inc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 214423-002 | Jan 4, 2022 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Pharmadax Inc | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 203699-001 | Mar 30, 2020 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Pharmadax Inc | ENTECAVIR | entecavir | TABLET;ORAL | 212106-002 | Aug 10, 2020 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Pharmadax Inc | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 203028-001 | Mar 31, 2020 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Pharmadax Inc | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 201464-001 | May 25, 2012 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.